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Human birth defects involving the ventral body wall are common, yet little is known about the mechanism of body wall closure in
mammals. The AP-2a transcription factor knock-out mouse provides an exceptional tool to understand this particular pathology, since it has
one of the most severe ventral body wall closure defects, thoracoabdominoschisis. To gain insight into the complex morphological events
responsible for body wall closure, we have studied this developmental process in AP-2a knock-out mice. Several tissues involved in normal
ventral body wall closure are defective in the absence of AP-2a, including those associated with the primary body wall, the umbilical ring,
and the mesoderm of the secondary body wall. These defects, coupled with the expression pattern of AP-2a, suggest that AP-2a is involved
in multiple developmental mechanisms directing the morphogenesis of the ventral body wall, including cell migration, differentiation, and
death. There is a failure of migration and fusion of the body folds at the umbilical ring, as well as in the formation and migration of the
abdominal bands and ventral musculature. Furthermore, the mechanism of cell deposition at the umbilical ring is disturbed. Consequently, the
mesodermal compartment of the body wall is underdeveloped. We also suggest that AP-2a is required for signaling from the surface
ectoderm to the underlying mesoderm for proper development and closure of the ventral body wall. These findings provide a fundamental
understanding of how AP-2a functions in the closure of the ventral body wall, as well as offer insight into related human birth defects.
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Ventral body wall defects, including such anomalies as
gastroschisis and omphalocele, are observed in approxi-
mately one out of every 2000 live human births (Glasser,
2001), making this category of birth defects a relatively
common occurrence. Gastroschisis occurs when the midgut,
which normally develops outside of the body during em-
bryogenesis does not completely return to the body cavity,
resulting in a persistent umbilical hernia. Omphalocele is a
midline defect at the amnio-ectodermal transition, resulting
in an enlarged umbilical ring through which organs such as
the liver and gut abnormally protrude. Primary thoracoab-
dominoschisis is the more severe form of omphalocele, in0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: trevor.williams@uchsc.edu (T. Williams).which the entire ventral body wall remains open, and the
organs are exposed. A number of these ventral body wall
defects manifest in human syndromes including Beckwith-
Wiedemann Syndrome, Reiger Syndrome, Pentalogy of
Cantrell, and Thoracoabdominal Syndrome (Cantrell et al.,
1958; Carmi et al., 1990; Jorgenson et al., 1978; Rieger,
1935; Wu and Kushnick, 1974). Overall, though, the ma-
jority of body wall malformations are non-syndromic and
their mechanism of pathogenesis is unclear. Particular genes
or chromosomes have been linked to the specific syndromes
listed above (Carmi et al., 1990; Ferry and Cohen, 2002;
Gage and Camper, 1997; Maher and Reik, 2000; Martin et
al., 1992; Parvari et al., 1994; Semina et al., 1996), but in
general, human genetic studies have not greatly advanced
our understanding of the process of ventral body wall
closure. Indeed, theories concerning the mechanisms re-
quired for this critical process are mostly based upon
descriptive observations of both mouse and human embryo-
genesis in which the underlying tissue movements appear
similar (Hartwig et al., 1989, 1991; Herva and Karkinen-
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Allen, 1981; Van Allen et al., 1987). Moreover, although
ventral body wall defects associated with either mouse
mutants or human congenital abnormalities are regularly
reported, very few detailed studies exist on the development
and closure of the mammalian ventral body wall.
The developmental origins of the mammalian dorsal
and ventral body wall are independent processes. The
formation of the dorsal body wall is intimately linked with
gastrulation and neurulation. In contrast, ventral body wall
formation and closure occurs by a separate mechanism.
With respect to mouse development, the process of turning
occurs between E8.5 and E9.5, resulting in the formation
of the initial primary ventral body wall, which consists of a
thin epithelial membrane that is partially composed of
periderm. The generation of the mature secondary ventral
body wall occurs much later in embryogenesis—between
E12-E16.5—by a separate morphogenetic process. At
E12.0, the secondary body wall begins to form and replace
the primary body wall by migrating towards the ventral
midline. The thoracic secondary body wall consists of
keratinized epithelium, ventral musculature, rib primordia,
and sternal rudiments. The secondary body wall of the
abdomen is made up of skin, muscle, and abdominal band
derivatives.Fig. 1. Diagram of a normal ‘‘physiological’’ umbilical hernia at E13.5. The right e
the body wall of the embryo proper to the amnion covering the umbilical cord occ
portion of the diagram depicts the umbilical cord, which extends to the placenta. B
continuous with the ectodermal and mesodermal layers of the amnion. The mesod
body wall and the amnion. At this stage of development, the umbilical vessels and
hernial sac contains the midgut, which normally develops outside of the embryoAfter turning, the configuration of the mouse and human
embryo is similar (Kaufman and Bard, 1999). The umbilical
ring, in the middle of the abdomen on the ventral surface, is
central to ventral body wall closure in both of these species.
In human embryogenesis, this structure is formed at the
apex of four intraembryonic mesodermal folds that close
over the ventral surface: the cephalic fold (head), two lateral
folds (sides), and the caudal fold (tail) (Duhamel, 1963;
Grange et al., 1987; Hartwig et al., 1991; Moore, 1982). The
formation of the umbilical ring has not been well described
in the mouse; however, many aspects of body wall closure
appear similar in both mouse and human. Thus, we assume
that the murine umbilical ring is formed in a similar manner
to that which is described in the human. In both species, the
umbilical ring acts as a transition zone between the body
wall and the amnion—at the umbilical ring, both the
ectoderm and mesoderm of the ventral body wall are
continuous with the amnion that covers the connecting stalk
(or umbilical cord) and surrounds the embryo as a contin-
uous sac (Fig. 1) (Kaufman and Bard, 1999; Vermeij-Keers
et al., 1996). At the beginning of body wall closure, the
umbilical ring spans the entire ventral surface of the
embryo. However, as ventral midline fusion nears comple-
tion, the umbilical ring is confined to a small region at the
center of the abdomen. Thus, in relation to the overallnd of the diagram represents the umbilical ring, in which the transition from
urs. The embryo would normally reside to the right of this diagram. The left
oth the ectodermal (red) and mesodermal (blue) layers of the body wall are
erm (blue) of the hernial sac is also in continuity with the mesoderm of the
hernial sac reside in the proximal part of the umbilical cord, as shown. The
proper at this stage. (Adapted from Kaufman and Bard, 1999).
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umbilical ring decreases. It is proposed that cell death and
cell deposition are required to ensure that the umbilical ring
remains approximately the same absolute diameter during
this period of embryogenesis to allow for appropriate ventral
body wall closure (Hartwig et al., 1991).
At E14.5 in the mouse, the size of the umbilical ring is
still relatively large to facilitate the extension of the midgut
into the umbilical hernia (Fig. 1). This event, or physiolog-
ical umbilical hernia, also occurs in human embryos. Out-
side the body, the midgut has room to differentiate and
elongate because the stomach and liver are occupying most
of the peritoneal cavity at this time (Kaufman and Bard,
1999). The physiological umbilical hernia is contained in a
dedicated membrane sac that is contiguous with the meso-
dermal layer of the body wall which lines the peritoneal
cavity (Fig. 1) (Kaufman and Bard, 1999). The midgut
develops within this physiological umbilical hernia until
its return to the peritoneal cavity through the umbilical ring
around E16. At this point, the intraembryonic coelom is no
longer in direct contact with the extraembryonic coelom
(Russo et al., 1993). By E16.5, the ventral body wall has
completely closed around the umbilical vessels and fused at
the midline (Kaufman and Bard, 1999).
In concert with the development and migration of the
ventral body wall, condensations of mesenchyme (termed
the sternal and abdominal bands) migrate from both
directions around the body wall and meet at the ventral
midline. Sternal bands, originating in the dorsolateral body
wall, migrate around to the ventral surface and fuse to
form the sternum; thus, contributing to the formation of the
thoracic ventral body wall (Bryson, 1945; Chen, 1952,
1953; Gladstone and Wakeley, 1932; Klima, 1968, 1987).
Abdominal bands are associated with the closure of the
abdominal body wall following resolution of the umbilical
hernia (Munger and Munger, 1991). By E15.5, the ab-
dominal bands have migrated around from either dorsolat-
eral direction and met at the midline where they are
involved in forming a subset of the abdominal muscula-
ture. Anterior cutaneous nerves form in association with
the abdominal bands. These nerves co-migrate with the
abdominal bands, and innervate the skin on either side of
the ventral midline in mammals.
Within this descriptive framework several theories have
been proposed for the pathogenesis of body wall defects in
human embryogenesis, but the mechanisms of mammalian
ventral body wall closure are still very poorly understood.
However, what is clear is that a range of environmental and
genetic insults can lead to the diverse pathologies associ-
ated with body wall closure defects. Such defects can result
from radiation, chemicals or drug toxicity, or chromosomal
manipulation (Barbieri et al., 1986; Hillebrandt et al., 1998;
Padmanabhan, 1998; Pampfer and Streffer, 1988; Price et
al., 1987; Rutledge, 1997). A selective number of mutant
mouse strains also exhibit various severities of body wall
defects. In particular, mutations in a limited number oftranscription factors, cell signaling molecules, and pro-
teases are associated with varying degrees of body wall
closure defects (Dunker and Krieglstein, 2002; Eggen-
schwiler et al., 1997; Hasty et al., 1993; Manley et al.,
2001; Nabeshima et al., 1993; Roebroek et al., 1998;
Schorle et al., 1996; Suzuki et al., 1996; Zhang et al.,
1996). In spite of these models, the absence of a robust
fundamental theory for how body wall closure occurs in the
mouse has hampered any detailed mechanistic insight into
how such genes might regulate this important developmen-
tal program.
The transcription factor AP-2a null mouse represents a
powerful genetic and molecular implement to study
mammalian ventral body wall closure. The loss of AP-
2a generates an extensive and fully penetrant ventral
body wall defect, akin to thoracoabdominoschisis and
other limb-body wall defects observed in human fetuses
(Schorle et al., 1996; Zhang et al., 1996). AP-2a belongs
to the AP-2 transcription factor gene family which is
composed of five members in both mice and humans:
AP-2a, AP-2h, AP-2g, AP-2y, and AP-2q (Bosher et al.,
1996; Chazaud et al., 1996; Feng and Williams, 2003;
Moser et al., 1995; Oulad-Abdelghani et al., 1996;
Williams et al., 1988; Zhao et al., 2001). Although AP-
2h and AP-2g are known to be important for develop-
ment (Auman et al., 2002; Moser et al., 1997b; Werling
and Schorle, 2002), only AP-2a is linked to body wall
closure (Nottoli et al., 1998; Schorle et al., 1996; Zhang
et al., 1996). AP-2a null embryos die perinatally and
have severe congenital defects that affect the neural tube,
face, limbs, eyes, heart outflow tract, and ventral body
wall (Brewer et al., 2002; Nottoli et al., 1998; Schorle et
al., 1996; West-Mays et al., 1999; Zhang et al., 1996).
The body wall defects are a direct result of the loss of
AP-2a, since a large percentage of chimeric embryos
(composed of wild-type and AP-2a null cells) showed a
body wall defect, either in combination with other
defects, or in isolation (Nottoli et al., 1998). Here, we
have utilized various AP-2a mouse models to probe how
this transcription factor regulates body wall closure.
Based on our analysis, we propose that appropriate
communication between epithelial and mesenchymal com-
partments of the embryo is central to body wall forma-
tion, and that AP-2a has a vital mechanistic role in this
developmental process.Materials and methods
Genotyping of adult and embryonic mice
Adult mice carrying one copy of the knock-in allele
(Brewer et al., 2002) were identified either by PCR analysis
using the primer pair neo 3VKO and Kyko3 (Brewer et al.,
2002) or by assaying for h-galactosidase activity on
isolated tail biopsies. For PCR analysis, DNA from adult
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DNeasy tissue kit (Qiagen). Alternatively, tails were fixed
in 0.25% glutaraldehyde in phosphate-buffered saline
(PBS) for 30 min at 4jC, washed in PBS, and stained
for h-galactosidase activity by standard procedures (Hogan
et al., 1994). For embryo analysis, homozygous knock-in
embryos were identified by their distinctive morphology
which phenocopied the original knock-out alleles (Schorle
et al., 1996; Zhang et al., 1996). The presence of the
knock-in allele in heterozygous embryos was determined
using both PCR and h-galactosidase staining protocols (as
above).
Detection of b-galactosidase activity in whole-mount and
sectioned embryos
Heterozygous AP-2a knock-in mice were mated, and
noon of the day of the copulatory plug was considered 0.5
days post-coitum (dpc). Embryos were taken at appropriate
developmental time points, fixed in 0.25% glutaraldehyde in
PBS for 30 min at 4jC, and washed extensively in PBS,
then incubated overnight in X-gal following standard pro-
cedures (Hogan et al., 1994). After post-fixing in 4%
paraformaldehyde, embryos were photographed, and subse-
quently dehydrated and embedded in paraffin for sectioning.
Cryostat sections of E15.5 embryos embedded and frozen in
OCT were X-gal stained as described previously (Hogan et
al., 1994; Jiang et al., 2000). Sections were counterstained
with nuclear fast red.
Whole-mount and sections of body wall morphology
Embryos of the appropriate developmental stages were
isolated in ice-cold PBS and fixed in either 4% parafor-
maldehyde, Bouin’s fixative (71% picric acid, 24% form-
aldehyde, 5% glacial acetic acid), or 10% neutral buffered
formalin (pH 7.4–7.8) at 4jC overnight. Body wall
morphology was examined and photographed in wild-type,
AP-2a+/KI, and AP-2a KI/KI whole embryos. The um-
bilical ring diameter of E15.5 wild-type (n = 9) and AP-2a
knock-out embryos (n = 6) was measured as follows:
photos were taken on a Wild M400 dissecting scope with
a Nikon CoolPix digital camera focusing on the region of
the umbilicus, transferred into Photoshop, increased to
50% screen size, and subsequently measured using the
MeasureTool. Measurement units are thus arbitrary. Em-
bryos were embedded in paraffin as described (Kaufman,
1992), and sectioned at 8 Am. The histology was observed
using hematoxylin and eosin staining, or h-galactosidase
detection with nuclear fast red counterstain (as described
above).
Silver staining
Silver staining was performed to visualize the anterior
cutaneous nerves that are associated with the abdominalbands. Embryos at E12.5–E14.5 were fixed in 10% neutral
buffered formalin, and embedded in paraffin as described
elsewhere (Kaufman, 1992). Eight-micrometer sections
were cut and floated on poly-L-lysine (Sigma) coated
slides. The ammoniacal silver staining method was per-
formed essentially as described (Sevier and Munger, 1965).
Sections were counterstained with nuclear fast red.
Immunohistochemistry
The day of the copulatory plug was considered E0.5.
Embryos were dissected out at appropriate time points,
and fixed in 10% neutral buffered formalin overnight at
4jC. Embryos were then dehydrated, embedded in paraf-
fin, and serially sectioned at 8 Am. Two different immu-
nohistochemistry protocols were utilized: one for a-
smooth muscle actin and one for myogenin. For a-smooth
muscle actin: sections were deparaffinized and heated for
2.5 min in citrate buffer (pH 6.0) in a microwave oven at
1350W for the purpose of antigen retrieval. Sections were
blocked according to the suggested protocols of the
Avidin/Biotin Blocking Kit (Vector Laboratories), fol-
lowed by a further round of blocking using procedures
outlined in the M.O.M. Immunodetection Kit (Vector
Laboratories). Mouse sections were stained with the
primary antibody mouse anti-a-smooth muscle actin,
Clone 1A4 (1:300 dilution; Sigma). The reaction was
visualized with nickel-intensified 3,3V-diaminobenzidine
(DAB; Vector Laboratories) from the DAB Peroxidase
Substrate kit (Vector Laboratories), and sections were
counterstained with nuclear fast red. This protocol was
performed as described (Dunker and Krieglstein, 2002).
For myogenin: sections were deparaffinized, and antigen
unmasking was performed by heating the sections for 30
min in Target Retrieval Solution (DAKO Corporation) as
described in the instruction manual. The sections were
treated with 3% hydrogen peroxide in tap water for 5
min, then blocked with both the avidin-biotin blocking kit
(Vector Laboratories) and the blocking reagent that is
included in the Vector M.O.M. kit (Vector Laboratories).
Instructions for the Vector M.O.M. kit were followed.
Addition of the mouse monoclonal anti-rat myogenin
antibody, Clone F5D (1:40 dilution; DAKO Corporation)
was followed by incubation with M.O.M. biotinylated
anti-mouse IgG reagent. The reaction was visualized with
DAB (Vector Laboratories), and the sections were coun-
terstained with methyl green. No specific cellular staining
was observed in the absence of either of the primary
antibodies.
Connective tissue
Connective tissue was stained with Gomori’s One-Step
trichrome staining procedure (Gomori, 1950), as performed
by the Department of Pathology Research Histology Lab
(Yale University).
Fig. 2. Thoracoabdominoschisis and the umbilical ring. (A, outlined in
black in C) The size of the umbilical ring in an E15.5+/KI embryo is only
large enough to support the umbilical cord, which at this stage of
development only encloses the umbilical artery and umbilical vein. (B) In
an E15.5 AP-2a KI/KI embryo, the liver and gut protrude through an
abnormally large umbilical ring (outlined in black in D), and so partially
reside in the extra-embryonic coelom. The abdominal organs have been
removed in Panel D to make visible the enlarged size of the umbilical ring.
Panels C and D are higher magnifications of the umbilicus region in Panels
A and B, respectively. (E, F) Transverse sections through the umbilical
region of E13.5+/KI (E) and AP-2a KI/KI (F) embryos. The arrows are
positioned at the margins of the umbilical ring, indicating the diameter. At
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Apoptotic cell death in the body wall of wild-type and
AP-2a KI/KI embryos was detected by TUNEL labeling.
Embryos were fixed in 10% neutral-buffered formalin
overnight at 4jC, embedded in paraffin, and sectioned at
8 Am. Apoptotic cells were detected with the ApopTagR in
situ apoptosis detection kit (Chemicon) following the man-
ufacturer’s instructions. Sections were counterstained with
methyl green.
Cre/loxP methodology
The conditional AP-2a Alflox line was generated as
described elsewhere (Brewer et al., in press), and bred to
homozygosity. Foxg1-Cre mice (He´bert and McConnell,
2000) were crossed with heterozygous AP-2a:LacZ knock-
in (KI) mice (Brewer et al., 2002). To obtain the desired
genotypic embryos for analysis, Foxg1-Cre; KI mice were
mated with homozygous AP-2a floxed mice. Embryos were
taken at appropriate developmental timepoints, fixed in 10%
neutral buffered formalin (pH 7.4–7.8) at 4jC overnight, and
examined for body wall defects. Genotyping for the Alflox
allele was performed by PCR using the following primers:
Alflp 5V-CCT GCC TTG GAA CCA TGA CCC TCA G-3V,
Alflox4 5V-CCC AAAGTG CCT GGG CTGAAT TGA C-3V,
and Alfscsq 5V-GAATCTAGCTTGGAGGCTTATGTC-3V.
These primers are able to distinguish a wild-type allele (490
bp), the intact floxed allele (Alflox) (560 bp), and the deleted
floxed allele (185 bp). Genotyping for the Cre allele was
accomplished by PCR amplification using primers Cre1 5V-
GCT GGT TAG CAC CGC AGG TGT AGA G-3Vand Cre3
5V-CGC CATCTT CCAGCAGGCGCACC-3V. A total of 82
embryos were examined between E15.5 and E18.5, 57 of
which were control embryos that lacked the appropriate
mutant AP-2 allele in combination with the Foxg1-Cre trans-
gene, and 25 of which had a mutant genotype. None of the
control embryos had body wall closure defects. With respect
to the mutants, 10 of the 25 embryos displayed varying
degrees of ventral body wall defects.
S. Brewer, T. Williams / Developthis stage of development, the gut normally develops outside of the
peritoneal cavity (E). In the KI/KI, the liver and gut are both observed
projecting through the enlarged hole in the abdomen at the umbilical ring
(F). The whole-mount embryos (A–D) were stained in X-gal, and the
sections (E, F) were hematoxylin and eosin stained. Abbreviations: liv,
liver; g, gut; KI, knock-in.Results
Morphological defects associated with the ventral body wall
in AP-2a knock-out embryos
Several defects can be discerned from the gross morpho-
logical analysis of AP-2a knock-out mice, including cranio-
facial defects, exencephaly, and absence of the ventral body
wall (Schorle et al., 1996; Zhang et al., 1996). Zhang et al.
(1996) categorized the ventral body wall defect observed in
AP-2a null embryos as a primary thoracoabdominoschisis
(Fig. 2B). In general, the organs of the thorax (heart and
lungs) and abdomen (liver and gut) can be discerned abnor-
mally extruding through the ventral body wall of both theAP-2a knock-out and the related AP-2a:LacZ knock-in (KI/
KI) mouse (Fig. 2B and (Brewer et al., 2002)). In this study,
we investigated the AP-2a knock-out ventral body wall
defect in relation to developmental time and to the tissues
of the body wall. We then went on to examine the ventral
body wall defect at a cellular and molecular level. Using the
AP-2a:LacZ knock-in mouse enabled us to study in detail
the expression pattern of AP-2a in the body wall during
development (LacZ staining observed in Figs. 2–4 will be
discussed in more detail at the end of the results).
Fig. 4. The physiological umbilical hernia membrane and the genital
tubercle. (A–BV) Transverse sections through the umbilical region of an
E13.5 +/KI (A, AV) or AP-2a KI/KI (B, BV) embryo. The extra-embryonic
yolk sac (ys) was kept intact so as to not disturb the membrane surrounding
the gut or the amnion (a). Panels AV, BV are higher magnifications of the
herniated gut represented in Panels A and B, respectively. (A) The herniated
gut (g) is normally surrounded by a thin mesodermally derived membrane.
(AV) A close-up of the herniated gut. Arrows depict the membrane that
surrounds the gut as it develops outside of the embryo. The amniotic fluid is
between the membrane and the amnion. (B) The membrane that normally
encloses the herniated gut is absent in an AP-2a deficient embryo. (BV) A
close-up of the umbilical region in a KI/KI. The arrowheads depict the lack
of the membrane that normally surrounds the herniated gut. The amniotic
fluid is in direct contact with the gut. Also, note that the body wall (bw) is
continuous with the amnion (a), and that the liver does not usually protrude
through the ventral surface in wild-type development. Sections were
counterstained with nuclear fast red. (C) E18.5+/KI embryo, lower
abdomen. The genital tubercle is formed by two bands that grow around
and fuse at the midline. (D) E18.5 KI/KI embryo. The external genital
tubercle, which has failed to fuse, is represented as separated protuberances
(denoted by the arrows). The lower abdominal body wall (denoted by the
asterisk) located between umbilical ring and the genital tubercle is also
completely absent. Embryos were whole-mount stained with X-gal.
Abbreviations: a, amnion; af, amniotic fluid; bw, body wall; E, embryonic
day; g, gut; gt; genital tubercle; hl, hind limb (removed); KI, knock-in; liv,
Fig. 3. Histology of the thoracic body wall. Transverse sections through the
thoracic body wall at the level of the heart. Primary thoracic body wall at
E11.5 in AP-2a +/KI (A, C) and AP-2a KI/KI (B, D) embryos. (A–B)
Thickness of body wall is relatively equivalent in more anterior sections.
(C–D) The most ventral portion of the body wall in some AP-2a KI/KI
embryos (D, denoted by asterisk) is thinner in comparison to a +/KI control
(C) in more posterior thoracic sections from nearer the abdomen. Normal
development of the thoracic body wall in E13.5 (E, G) and E15.5 (I, K) AP-
2a+/KI embryos. Malformation of the thoracic body wall in E13.5 (F, H)
and E15.5 (J, L) AP-2a KI/KI littermates. At E13.5, the heart is covered by
a continuous ventral body wall (E, arrows in G), unlike in some KI/KI
embryos in which the body wall is discontinuous (F, arrows in H). Strong
AP-2a:LacZ expression is observed at the leading edges of the body wall in
the KI/KI (H). By E15.5 in wild-type development, the sternum has formed
at the ventral midline (I, K). The arrows in (K) signify the complete closure
of the ventral body wall. In this E15.5 KI/KI embryo, the ventral body wall
is completely absent (J, arrowheads in L), leaving the heart outside the
embryo. Sections are stained with X-gal and counterstained with nuclear
fast red. Boxes in (E, F, I, J) denote the higher magnifications represented in
(G, H, K, L), respectively. Abbreviations: lb, limb bud; h, heart; l, lung; s,
sternum; vc, vertebral column; E, embryonic day; KI, knock-in.
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Before E15.5, the ventral surface is covered by a
primary body wall composed of a single layer of periderm,
overlying several layers of epithelial tissue. An examina-
tion of the AP-2a null mouse at E9.5 and E10.5 indicated
that there were no gross morphological differences from
liver; t, tail (removed); uc, umbilical cord; ys, yolk sac.
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wall at these early developmental stages (data not shown,
also see Brewer et al., 2002). By E11.5, all mutants
examined had an apparently normal body wall morphology
in more anterior thoracic regions (Figs. 3A, B), but an
occasional mutant had a thinner primary body wall at the
ventral midline closer to the abdominal region-possibly
reflecting the influence of the defective umbilical ring
(Figs. 3C, D; and see below). By E12.5, the relative
thinning of the primary body wall at the ventral midline
became more prominent in mutant versus wild-type em-
bryos, and now occurred more rostrally in the thorax too
(data not shown). At E13.5, the wild-type heart is covered
by a relatively thin primary ventral body wall that does not
yet contain musculature or a rib cage and sternum (Figs.
3E, G). In contrast, E13.5 AP-2a KI/KI embryos lack this
thin ventral body wall (Figs. 3F, H). Instead, KI/KI
embryos are observed as either containing a thoracic
ventral body wall that consists of only one to two layers
of epithelium (data not shown) or a discontinuous body
wall (Figs. 3F, H). By E15.5 in normal development, the
rib cage has formed, the sternal rudiments have fused at
the midline, and the thoracic secondary body wall has
completely closed (Figs. 3I, K). In the E15.5 KI/KI
embryo shown in Figs. 3J, L, an extreme failure in body
wall formation is observed. There is absolutely no sign of
a primary or secondary thoracic body wall, and the heart is
anteriorly displaced and completely outside of the embryo
proper, characteristically termed ectopia cordis (Figs. 3J,
L). It is unlikely that experimental mechanical disruption
caused the ventral surface to rupture resulting in its
absence, as some dissections for histology were performed
without disturbing the yolk sac. As at E13.5, AP-2a
knock-outs at this stage show differences in the develop-
ment of the ventral body wall visible as either a one layer
thick continuous membrane or two dorsolateral body walls
that remain extremely lateral to the ventral midline (Fig. 3
and data not shown).
Abdominal: umbilical ring
As the ventral body wall closes in wild-type develop-
ment, the umbilical ring is resolved to a diameter that
supports only the umbilical cord (Figs. 2A, C) (Kaufman
and Bard, 1999). In contrast, the umbilical ring of E15.5
AP-2a knock-outs remains abnormally large (Figs. 2B,
D). On average, the diameter of the umbilical ring of an
E15.5 AP-2a knock-out is 7 to 12 times larger than the
diameter of a wild-type umbilical ring at the equivalent
stage of development (data not shown, see Materials and
methods). In the AP-2a null embryo, the abdominal
organs, including the liver and gut, protrude through this
enlarged umbilical ring into the extraembryonic coelom
(Figs. 2B, D). The transition from the amnion to the
ectoderm of the body wall is still continuous in the
knock-out, but it is displaced to the margins of the bodywall defect (at the enlarged umbilical ring). Therefore, the
amnion cannot apply itself to the connecting stalk in the
ventral region of the embryo at the umbilical ring. In the
transverse section shown in Fig. 2F, the abdominal
organs protrude through the enlarged umbilical ring of
an E13.5 knock-out embryo. In comparison, only the
umbilical hernia and the umbilical cord typically reside at
the umbilical ring at this stage of normal development
(Fig. 2E).
Abdominal: umbilical hernia membrane
In a wild-type embryo before the resolution of the
umbilical hernia, the membrane surrounding the umbilical
hernia is observed tightly enclosing the gut that is devel-
oping outside of the embryo proper (Figs. 4A, AV).
Amniotic fluid typically resides between the amnion and
the ectoderm on the dorsal and lateral portions of the
embryo proper. On the ventral surface, the membrane
surrounding the umbilical hernia protects the internal
organs of the embryo from the amniotic fluid (Fig. 4AV).
In contrast, this membrane is completely absent in AP-2a
knock-out embryos, and consequently, the amniotic fluid
is in direct contact with the exposed abdominal organs
(Figs. 4B, BV).
Lower abdominal
AP-2a knock-out mice contain a multitude of midline
defects, including neural tube, face, tongue, and body
wall defects (Schorle et al., 1996; Zhang et al., 1996).
The extent of the midline ventral body wall defect in AP-
2a knock-out mice extends the length of the embryo
from the thoracic region down through the abdomen and
into the inguinal region, including the genital tubercle.
The external genital tubercle is present as separated
protuberances, or bifid genital tubercle (Fig. 4C compared
to Fig. 4D).
Absence of abdominal bands in AP-2a knock-outs
One possible explanation for the failure of body wall
closure in AP-2a knock-out embryos, at least in the
abdominal region, is a malformation of the abdominal
bands. A silver staining technique was employed to
identify the cutaneous nerves that are associated with the
abdominal bands, and subsequently to locate these latter
mesodermal structures.
In E13.5 and E14.5 wild-type mouse embryos, conden-
sations of mesoderm and the associated anterior cutaneous
nerves are observed at the level of the umbilical hernia
(Figs. 5A, C, E). By E14.5 in the wild-type, the abdominal
bands have almost reached the ventral midline from either
lateral direction. Furthermore, the abdominal bands have
begun to differentiate into three layers of abdominal mus-
culature (Fig. 5E).
Fig. 5. Abdominal bands. Transverse sections through the abdomen of
E13.5 (A–D) and E14.5 (E–F) AP-2a+/KI (A, C, E) and AP-2a KI/KI (B,
D, F) embryos. (A, C) In E13.5+/KI embryonic sections, the abdominal
bands are represented as condensed bands of mesoderm in the lateral body
wall (arrows) and are associated with the anterior cutaneous nerve (stained
in brown in the abdominal band). (B, D) In E13.5 KI/KI embryonic
sections, the abdominal bands and associated anterior cutaneous nerves are
completely missing (arrowheads). (E) At E14.5, the abdominal bands (ab)
of a wild-type embryo have almost reached the ventral midline. Note that
the abdominal bands at this stage have begun to differentiate into three
layers of abdominal muscles (mus) (also seen in Fig. 6H–I). (F) In an
E14.5 KI/KI embryonic section, the abdominal bands are completely absent
(arrowheads) and there is no sign of musculature. The lateral body wall is
disorganized in comparison to the wild-type. The membrane between the
lungs (l) and liver (liv) is the diaphragm. (A–D) Sections were silver-
stained and counterstained with nuclear fast red. (E–F) Sections were
stained with hematoxylin and eosin. Abbreviations: ab, abdominal band; d,
diaphragm; KI, knock-in; l, lung; lb, limb bud; liv, liver; n, nerve; r, rib.
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the secondary body wall form (i.e., dorsal muscle rudi-
ments, rib primordia, mammary buds, dorsolateral mature
keratinized skin), but they remain at an abnormal dorso-
lateral position and do not migrate to the ventral surface
(data not shown). However, the mesodermal abdominal
bands, a large component of the secondary body wall, are
completely absent in E13.5 and E14.5 AP-2aKI/KI embryos(Figs. 5B, D, F). Furthermore, E14.5 AP-2a null embryos
show a lack of ventral body wall muscle definition (Fig. 5F).
The margins of the body wall defect also remain highly
disorganized.
Connective tissue defects in AP-2a null embryos
Transverse sections through the AP-2a knock-out
embryos at the level of the lungs/liver show that the
layer of connective tissue under the epidermis in the
dorsolateral body wall is much thicker in comparison to
a wild-type (Figs. 6A, D). Connective tissue is observed
with a trichrome staining procedure that labels collagen
and connective tissues, as well as muscle. In E13.5 wild-
type embryos, the connective tissue exists as a thin
stratified layer with parallel layers of collagen fibers
(Figs. 6B–C). In contrast, the cells and collagen fibers
of a null embryo of an equivalent age remain highly dis-
organized, and the cellular density is lower (Figs. 6E–F).
We have also observed an apparent lack of turgor and
elasticity in the surface epithelium of several knock-out
embryos examined by SEM (data not shown). Therefore,
defects in both the connective tissue and skin suggest that
the mechanical tension presumably required for proper
closure of the ventral body wall is absent in AP-2a
knock-out embryos.
Lack of ventral body wall musculature in AP-2a null
embryos
In wild-type embryos, body wall development includes
the morphogenesis of thoracic and abdominal musculature.
To investigate whether AP-2a mutant mice exhibit normal
muscle development despite the lack of ventral body wall
closure, two different skeletal muscle markers were used: a-
smooth muscle actin and myogenin.
a-smooth muscle actin, a striated muscle cell, feto-
embryonic actin marker, is predominately expressed in
myoblasts as they are differentiating (Babai et al., 1990).
At E13.5 and E14.5, smooth muscle actin-positive cells
clearly mark the three layers of the ventral abdominal
muscle, as well as the cutaneous maximus muscle, in a
wild-type embryo (Figs. 6G–I and data not shown). The
three layers represent the transversus abdominis, internal
oblique, and external oblique of the abdominal body wall
musculature (Fig. 6I). It was also observed that the muscle
bands in an E14.5 wild-type embryo have migrated further
towards the midline than the muscle bands in a similar
transverse section of an E13.5 wild-type embryo (data not
shown).
In E13.5 and E14.5 AP-2a KI/KI embryos, smooth
muscle actin-positive cells are present in the dorsal and
dorsolateral regions of the embryo (Figs. 6J–L and data
not shown), similar to the staining observed with the
myogenin marker (see below). The cutaneous maximus
muscle is present, as well as intercostal and serratus
Fig. 6. Connective tissue and musculature of the lateral and ventral body walls. Transverse sections through the abdomen, at the level of the lungs/liver, of
wild-type (A–C, G–I) and AP-2a KI/KI (D–F, J–L) embryos. All panels have the same dorsal (D)–ventral (V) axis as shown in Panel G. (A–F) Sections are
stained with Gomori’s one-step trichrome. Higher magnifications of Panels A, D are shown in Panels B, E and Panels C, F, respectively. (B, E) Notice that the
connective tissue is much thicker and highly disorganized in Panel E (KI/KI) in comparison to Panel B (WT). (C) In an E13.5 wild-type embryo, the
connective tissue is observed as a thin layer of unidirectionally oriented cells with parallel layers of collagen fibers. (F) In an E13.5 AP-2a KI/KI embryo, the
cells of the connective tissue are not stratified, and collagen fibers remain disordered (in comparison to C). (G–L) Sections are stained for a-smooth muscle
actin, which marks both embryonic skeletal muscle and smooth muscle, and counterstained with nuclear fast red. The black boxes in Panels G, J define the
regions of higher magnification seen in Panels H–I and Panels K–L, respectively. (H, I) Appropriate lateral and ventral body wall muscles are present in wild-
type embryos. Notice the three layers of abdominal muscles (eo, io, and ta) as well as the cutaneous maximus muscle (cm). (K, L) These three layers of
muscles are absent in the KI/KI embryo (arrowhead), although the cutaneous maximus muscle and dorsal musculature are present. Note that the diaphragm is
present in both wild-type and KI/KI embryos (compare G to J). Abbreviations: cm, cutaneous maximus muscle; ct, connective tissue; d, diaphragm; e,
epidermis; E, embryonic day; eo, external oblique; ic, intercostal muscles; io, internal oblique; KI, knock-in; l, lung; liv, liver; rp, rib primordia; s, serratus
muscle; ta, transversus abdominis; WT, wild-type.
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Table 1
Comparison of apoptosis levels in the cells of the lateral and ventral body
wall of wild-type and AP-2a-deficient embryos
E12.5 E14.5
Wild-type AP-2a KI/KI Wild-type AP-2a KI/KI
66 351 17 136
35 173 22 89
43 207 21 131
24 189 25 156





Average: 41 Average: 217.4 Average: 20.7 Average: 123.7
Note. The total number of apoptotic cells was counted from the entire
existing lateral and ventral body wall at the level of the umbilical ring in
various 8-Am transverse sections. At E12.5, the area and cell density of the
AP-2a KI/KI body wall was relatively equivalent to that of a control wild-
type. Near the umbilical ring, 5% of wild-type cells and 21% of mutant cells
were apoptotic. In the lateral region of the body wall, 1% of wild-type cells
and 10% of mutant cells were apoptotic. At E14.5, 2–3% of wild-type cells
adjacent to the umbilical ring and < 1% of cells at the lateral margins of the
body wall were apoptotic. There is no ventral body wall present in most
AP-2a KI/KI embryos, therefore, cell death was counted in the entire
disorganized lateral body wall up to the level of the enlarged umbilical ring.
On average, 10% of the cells in this region were apoptotic. Student’s t test
for probability at E12.5: P < 0.005; at E14.5: P < 0.0001. Similar results
were obtained from a second independent experiment.
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throughout the ventral musculature in wild-type embryos,
the smooth muscle actin-positive cells are not observed in
the lateral or ventral body wall of AP-2a null embryos
(Fig. 6L). The lack of positive cells correlates to the
complete absence of the abdominal muscles in the ventro-
lateral and ventral regions of the AP-2a null embryo. The
diaphragm, which is partly derived from the body wall,
develops in both wild-type and AP-2a KI/KI embryos
(data not shown). Still, the morphology of the diaphragm
in knock-out embryos is atypical because it cannot attach
to the ventral body wall (data not shown).
We also examined a second marker, myogenin, which
is expressed in migrating muscle precursors during myo-
genesis at E12.5–E13.5. In both wild-type and AP-2a
KI/KI embryos, myogenin-positive cells were observed
migrating in appropriate numbers and distribution from
the somites (data not shown). However, in contrast to
wild-type embryos, myogenin expression is ventrally
truncated in the lateral body wall of KI/KI embryos (data
not shown) consistent with the a-smooth muscle actin
data.
Cell death and cell proliferation
The processes of cell proliferation and cell death are
postulated to be integrant mechanisms in the complex
process of body wall closure (Hartwig et al., 1989, 1991;
Hirata and Hall, 2000; Lin et al., 1999; Smits-van Prooije
et al., 1987, 1988; Thompson and Bannigan, 2001; Ver-
meij-Keers et al., 1996; Wei and Sulik, 1993). There were
no obvious differences in proliferation as measured by
BrdU staining in the dorsolateral body wall between E13.5
wild-type and AP-2a null embryonic sections (data not
shown).
To observe possible alterations in cell death, ApopTagR
staining was utilized (Chemicon). This apoptosis detection
system was applied to E11.5 transverse sections from
wild-type and AP-2a KI/KI mice at the level of the thorax.
Similar relative levels of apoptosis were observed in the
primary body wall of both wild-type and mutant embryos,
although the cell death occasionally appeared more local-
ized to cells of the mutant periderm (data not shown).
Next, we examined E12.5 and E14.5 wild-type and AP-2a
KI/KI transverse tissue sections through the body wall at
the abdominal level, i.e., at the level of a normal umbilical
ring (a region equivalent to that shown for an E13.5
mouse in Figs. 2E, F). In E12.5 and E14.5 wild-type
controls, apoptotic cells were counted in the lateral and
ventral body walls at the level of the umbilical ring (Table
1). The majority of the cell death (>90%) occurred in the
tissue of the body wall immediately adjacent to the
umbilical ring on the ventral surface. There was a minimal
amount of cell death (<10%) in the lateral body wall of
E12.5 and E14.5 wild-type embryos (data not shown). In
the AP2a KI/KI embryos, apoptotic cells were countedin the lateral body wall up to the margin of the enlarged
umbilical ring. Cell death was especially concentrated at
the margin of the body wall defect around the umbilical
ring, but was also consistently detected at an increased
level along the length of the dorsolateral body wall (Table
1 and data not shown). Overall, we show that there is a 5-
to 6-fold increase in apoptosis at both stages of develop-
ment in the AP-2a knock-out body wall in comparison to
wild-type (Table 1).
Expression of AP-2a in the body wall
Despite previous antibody and RNA in situ staining,
endogenous AP-2a expression has not been observed on
the ventral surface of wild-type mice. The generation of
the AP-2a:LacZ knock-in mouse (Brewer et al., 2002)
provided us with a more sensitive detection system to
study the expression of AP-2a in relevant tissues pertain-
ing to the development of the body wall. From E9.5 to
E13.5, AP-2a expression was observed in heterozygous
knock-in mice (+/KI) as intense LacZ staining in the
ectoderm of the dorsal surface. Expression was also
visualized as punctate staining in the peridermal layer of
the ventral and lateral primary body wall, but not in the
underlying cell layers (Figs. 7A–C and data not shown).
At E13.5, the margin of the intense staining on the
dorsolateral surface correlates with the forefront of the
migrating abdominal bands (Fig. 7H). Similar AP-2a:LacZ
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mice throughout these stages in spite of the escalating
body wall closure defects (Figs. 7D–F and data not
shown). For example, in an E13.5 KI/KI embryo, intense
AP-2a:LacZ expression is observed dorsolaterally as in the
wild-type, even though no abdominal bands are present
(Fig. 7I).
E13.5 AP-2a KI/KI embryos can be distinguished from
wild-type controls by one of the following two character-
istics associated with the primary body wall. In someE13.5 KI/KI embryos, only a thin one or two layer
epithelial membrane was observed covering the ventral
portion of the developing embryo. The periderm of this
structure showed punctate staining as observed for the
thicker primary body wall of +/KI embryos. In other KI/
KI embryos, the body wall stops at a lateral position as
shown in Fig. 7D. Sometimes, a region of high LacZ
expression for the AP-2a locus was observed ventral to the
dorsolateral margin, at the edge of the body wall defect
(Figs. 7D, G; see also Fig. 3H).
By E14.5, more consistent differences in AP-2a:LacZ
expression between +/KI and KI/KI embryos began to
develop. In comparison to E13.5 +/KI mice, more intense
AP-2a staining was seen on the ventral surface of an E14.5 /
KI corresponding with the expression of this gene in the
ectoderm of the secondary body wall as it migrated towards
the midline (data not shown). However, unlike at E13.5,
E14.5 KI/KIs do not resemble their heterozygous littermates
in the expression of AP-2a:LacZ. At E14.5, KI/KI embryos
showed intense AP-2a:LacZ expression up to a dorsolateral
boundary, then show punctated expression (data not shown).
The lack of AP-2a:LacZ expression on the ventral surface
correlates with the defect in secondary ventral body wall
closure.
By E15.5, there is no boundary of AP-2a expression
between the dorsal and ventral surfaces of +/KI embryos
(Figs. 8A–B). There are consistently high levels of AP-
2a expression in the ectoderm on both the dorsal and
ventral surfaces indicating completion of body wall clo-
sure. In E15.5 KI/KIs, there is a persistent boundary of
AP-2a:LacZ expression where the dorsal and ventral sur-
faces meet, similar to E13.5 KI/KIs. On the dorsal surface,
there are high levels of AP-2a:LacZ expression, while on
the dorsolateral surface, there is only punctate staining
(Figs. 8C–D).Fig. 7. AP-2a:LacZ expression in the body wall of E13.5+/KI and AP-2a
KI/KI embryonic sections. Transverse sections through the abdomen of a
+/KI (A–C, H) and a KI/KI (D–G, I) littermate. (A) In an E13.5+/KI,
AP-2a:LacZ expression is present as intense staining in the surface
ectoderm of the dorsal body wall (B) and as punctate staining in the
primitive surface ectoderm of the dorsolateral body wall (C). (D) In an
E13.5 KI/KI, AP-2a:LacZ expression is present as intense staining in the
surface ectoderm of the dorsal body wall (E) and as punctate staining in
the primitive surface ectoderm of the dorsolateral body wall (F). This
staining pattern is similar to a +/KI littermate at this stage of development.
In some E13.5 KI/KI embryos, as shown here (D, G), the body wall stops
at a more lateral position and is not continuous around the ventral surface
as in the +/KI (A). A region of high AP-2a expression is observed more
ventral to the dorsolateral margin, at the edge of the body wall defect (G).
(H– I) AP-2a:LacZ expression is observed in the differentiating epidermis
(blue staining). In the +/KI section (H), AP-2a expression corresponds to
the leading edge of the migrating abdominal band (designated by the
line). In the KI/KI section (I), this is not observed. Black boxes in (A, D)
define the regions shown at higher magnification in (B–C, E–G).
Sections are counterstained with nuclear fast red. Abbreviations: ab,
abdominal band; KI, knock-in; LE, leading edge; liv, liver; se, surface
ectoderm.
Fig. 8. AP-2a:LacZ expression in the body wall of E15.5+/KI and AP-2a KI/KI embryonic sections. Transverse sections through the abdomen of a +/KI (A, B)
and a KI/KI (C, D) embryo. On the dorsal surface, AP-2a:LacZ expression is visualized as intense staining in the surface ectoderm of the body wall in both
+/KI (A) and KI/KI (C) littermates. The ventral surface of the +/KI embryo shows similar intense staining (B). The dorsolateral surface of the KI/KI embryo (D)
shows only punctate staining in the primitive surface ectoderm indicative of a halt in the development or migration of the body wall over the ventral surface. This
punctate staining is similar to the staining seen on this surface at an E13.5 stage of development (see Fig. 7F). Sections are counterstained with nuclear fast red.
Abbreviations: KI, knock-in.
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wall closure defects
We have recently generated a new line of mice (Alflox)
in which essential AP-2a coding sequences have been
flanked by two loxP sites, creating a floxed allele of AP-
2a (Brewer et al., in press). These mice have been utilized
with several available Cre recombinase transgenic mouse
strains to probe the tissues through which AP-2a directly
regulates multiple aspects of development (Brewer et al.,
in press; Nelson and Williams, in press). In the course of
these studies, we found that mice containing one copy of
the AP-2a KI allele and one copy of the floxed allele in
combination with the Foxg1-Cre transgene (He´bert and
McConnell, 2000) frequently displayed ventral body wall
closure defects (Fig. 9). In mutant embryos, defects of the
ventral body wall included slits behind the ears and across
the neck, which sometimes extended down into the mid-
line of the thorax and/or abdomen (Fig. 9H and data not
shown). In addition, mutants were observed with an
enlarged umbilical ring through which the internal organs
(liver and intestines) extended to variable degrees (Figs.
9C–F), as well as abnormalities of the lower abdominalwall, including defective fusion of the genitalia (Figs. 9C,
E–F). Some mutants also lacked the mesodermal deriva-
tives of the ventral body wall, as shown in Fig. 9F. Thus,
due to the absence of the ventral abdominal musculature,
the organs can be observed through the thin primary body
wall (Fig. 9F). No defects were observed in the dorsal or
dorsolateral body wall (data not shown), a result which is
consistent with the AP-2a null phenotype (Schorle et al.,
1996; Zhang et al., 1996). Previously, it has been reported
that the major domain of Foxg1-Cre expression is in the
head, but that it is also sometimes expressed in patchy
regions of the trunk and tail ectoderm (He´bert and
McConnell, 2000). In relation to the ventral body wall
phenotypes described here, PCR analysis of the mutants
shown in Fig. 9 confirmed the deletion of the AP-2a allele
in the trunk ectoderm, although deletion could also be
observed in other tissues associated with the trunk in
which AP-2a expression was not observed (data not
shown). Overall, the data are compatible with the hypoth-
esis that deletion of AP-2a in the ectoderm is responsible
for the body wall closure defects. Moreover, the range of
body wall defects is consistent with the reported variability
in recombination levels in the ectoderm of the trunk
Fig. 9. Foxg1-Cre mediated deletion of AP-2a results in body wall closure defects. Ventral abdomen of E15.5 wild-type (A, B) and mutant (C–F) embryos. (A,
B) At E15.5, the body wall has completely closed around the ventral surface. Panels A and B show different stages of the intestines contained within the
umbilical hernia (uh) being returned to the peritoneal cavity. (C–F) Ventral body wall defects observed in mutant embryos in which AP-2a has been deleted
using the Foxg1-Cre transgene. The arrows (C, E–F) point to the failure in the caudal portion of the abdominal body wall to fuse, which affects the formation
of the genital tubercle. The asterisks (C–E) denote the abnormal protrusion of the liver through an enlarged umbilical ring (termed omphalocele). The bracket
in Panel F shows the absence of the abdominal musculature, so that the liver can be observed through the thin intact primary body wall. The umbilical hernia in
Panel F is normal. (G, H) Ventral view of E18.5 wild-type and mutant embryos. The arrowhead (H) shows a defect in the body wall that affects the closure of
the thorax. All embryos are oriented as in Panel A with the genital tubercle on the left and the face (not shown in some panels) on the right. Abbreviations: f,
face; gt, genital tubercle; hl, hind limb (removed); mut, mutant (embryos contain both Cre and deleted floxed AP-2a alleles); uc, umbilical cord; uh, umbilical
hernia; WT, wild-type.
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finitively exclude the possibility that transient expression of
AP-2a in another trunk tissue that is targeted by this Cre
recombinase might also be responsible for coordinating
ventral body wall closure.Discussion
Ventral body wall closure is a complex process that
involves the precise coordination of multiple developmental
mechanisms. Although several mouse mutants show body
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involving the body wall is extensive—very little is known
about the mechanisms surrounding ventral body wall clo-
sure. The discovery that the AP-2a null mouse has one of
the most severe ventral body wall defects known has
prompted our further analysis of how loss of this transcrip-
tion factor impacts body wall closure. Previous studies on
chimeric mice indicated that there is an independent re-
quirement for AP-2a in the development of the ventral body
wall (Nottoli et al., 1998). The current analysis now sup-
ports several roles for AP-2a in the closure of the ventral
body wall. There are subtle defects in the organization of the
primary body wall at early timepoints, and more pro-
nounced problems with the umbilical ring and with the
migration of the secondary body wall around the ventral
surface. Secondary body wall defects include the absence of
multiple mesodermal structures necessary for the proper
formation of the body wall, and disorganized connective
tissue. Our data also point to the potential importance of
epithelial–mesenchymal interactions in ventral body wall
formation—a mechanism that may also pertain to the body
wall closure defects seen in human embryogenesis.
A role for AP-2a in the migration and closure of the ventral
body wall
The earliest process related to the formation of the
ventral body wall involves the migration of four body folds.
The four mesodermal body folds (cephalic, caudal, and two
lateral) migrate and close over the ventral surface contrib-
uting to the formation of the thoracic and abdominal body
walls. The apex of the four folds forms the umbilical ring
(Duhamel, 1963; Grange et al., 1987; Hartwig et al., 1991;
Moore, 1982). Defective development of the umbilical ring
can lead to a developmental disturbance in the ventral body
wall.
In the analysis of AP-2a knock-out embryos, we found
that the umbilical ring is abnormally large compared to
wild-type, such that the liver and gut protrude through the
umbilical ring. This defect could be caused by the malfunc-
tion of two distinct developmental mechanisms: migration
of one or multiple primary mesodermal body folds and/or
insufficient cell deposition at the body wall placode located
at the umbilical ring (see below). Failure in the migration of
the cephalic fold, which normally forms the thoracic and
epigastric walls, can cause a multitude of defects, including
omphalocele, ectopia cordis, cleft sternum, and cardiac
defects. Failure of the lateral folds to migrate causes defects
in the closure of the ventral body wall. Finally, failure in the
migration of the caudal fold, which normally forms the
hypogastric and lower abdominal wall, causes cloacal
extrophy. AP-2a null embryos show defects caused from
failures in all four body folds. Evidence from the chimeric
studies further supports our proposition that the observed
body wall defects and enlarged umbilical ring partially
result from a malfunction in the migration of the primarybody fold(s). In addition to the abdominal and thoracic body
wall defects (as mentioned in the introduction), chimeras
also occasionally showed a slit behind the ears and/or a slit
in the body wall that extended between the ears across the
neck (Nottoli et al., 1998). This defect could result from a
failure in the cephalic fold to join with the lateral folds of
the body wall.
Furthermore, our expression data suggest that AP-2a has
a fundamental role in the process of secondary body wall
migration. Previous antibody and in situ studies have failed
to detect AP-2a on the ventral surface of wild-type embry-
os, despite the seemingly important role AP-2a plays in
ventral body wall closure. Through the use of LacZ knock-
in technology, AP-2a expressing cells have now been
observed in the periderm of the primary body wall and in
the ectoderm of the migrating secondary body wall of wild-
type embryos. Early in development (E13.5), AP-2a is
highly expressed on the dorsal and dorsolateral surface of
the body wall, and is minimally expressed on the ventral
surface. As development continues (E14.5–E16.0), AP-2a
is progressively expressed at a more intense level closer and
closer to the ventral midline. This expression coincides with
the progression of the secondary body wall towards its
closure at the ventral midline. Although many components
of the secondary body wall form in AP-2a KI/KI embryos,
including the mammary buds and sternal rudiments, these
remain abnormally lateral in position consistent with the
boundary of intense AP-2a:LacZ expression and the lack of
secondary body wall migration to the ventral surface in
knock-out embryos.
AP-2a, cell death, and cell deposition of the body wall
Mutations associated with the mouse AP-2 gene family
are frequently associated with an increase in cell death
(Moser et al., 1997a; Schorle et al., 1996; Zhang et al.,
1996). With respect to ventral body wall formation in the
AP-2a-null mice, beginning at E12.5, we see increased
apoptosis compared to wild-type in two major regions: the
umbilical ring and the lateral margins of the primary body
wall. Apoptosis associated with the lateral primary body
wall is mostly confined to the non-AP-2a expressing layers
underlying the AP-2a positive periderm. The increased cell
death in these regions of the primary body wall could
potentially cause a partial or even a catastrophic failure of
secondary body wall closure, possibly due to mechanical
disruption or defective cell–cell interactions. We further
hypothesize that the increased cell death at the umbilical
ring causes defects in two additional developmental pro-
cesses—the resolution of the physiological umbilical hernia
and the formation of the mesodermal derivatives of the
secondary body wall. Thus, our data support the theory that
human body wall defects could be caused in some instances
by a malfunction of the ectodermal placode (Hartwig et al.,
1989, 1991; Russo et al., 1993; Smits-van Prooije et al.,
1987, 1988).
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ectodermal placode located at the umbilical ring acts as a
transition zone, depositing mesoectodermal cells that will
eventually form the mesodermal structures of the ventral
body wall (including the muscles and connective tissue).
The cell deposition process involves adding cells to a
mesodermal compartment by the combined processes of
apoptosis of ectodermal cells and the disruption of the
underlying basement membrane, so that neighboring ecto-
dermal cells can be deposited into the mesoderm that lies
below (Smits-van Prooije et al., 1987; Vermeij-Keers and
Poelmann, 1980; Vermeij-Keers et al., 1996). Consequently,
a malfunction in the body wall placode could lead to
mesodermal underdevelopment of the ventral body wall,
as well as an enlarged umbilical ring (Hartwig et al., 1989).
Our studies show that AP-2a null embryos not only have an
abnormally large umbilical ring, but also display major
defects in the connective tissue and musculature of the body
wall. We postulate that the increased cell death in the
ectodermal placode of an AP-2a null embryo is mechanis-
tically responsible for the observed defects in the ventral
body wall, presumably by compromising the integrity of the
basement membrane and/or by disrupting the process of cell
deposition required to form the mesodermal compartment.
We further note that AP-2a null embryos have defects
associated with other developmental systems that involve
ectodermal placodes including the cranial ganglia, eyes,
neural tube, nose, branchial arches, and limbs. Thus, the
data obtained from an analysis of the body wall indicate that
AP-2a may have a more widespread role in the process of
cell deposition at the surface ectodermal placodes.
Defects involving the mesodermal compartment of the body
wall
The increased level of cell death in the body wall placode
of AP-2a null embryos directed our analysis to an examina-
tion of the mesodermal structures of the ventral body wall.
We discovered multiple defects in this compartment, includ-
ing lack of abdominal bands, lateral and ventral body wall
musculature, and the mesodermal membrane that surrounds
the physiological umbilical hernia. Munger and Munger
(1991) proposed that there is a close relationship between
the onset of cutaneous innervation and the migration of
mesodermal bands in the ventral body wall, such that if these
abdominal bands do not form or migrate appropriately, the
ventral body wall will not close normally. In AP-2a knock-
out embryos (E12.5–E14.5), there is a complete lack of
abdominal bands and their associated anterior cutaneous
nerves. The absence of the abdominal bands strongly corre-
lates with the observed ventral body wall closure defects in
AP-2a mutant embryos. The abdominal bands normally
encompass a large proportion of the volume of the ventral
body wall. They generate the three layers of abdominal
musculature, and form a further subset of abdominal muscles,
the primodia of rectus muscles, after fusion in the midline.The lack of abdominal bands supports both the defects in
mesodermal cell deposition at the body wall placode and the
failure in body wall migration/closure. Moreover, AP-2a
knock-out embryos have defects in the genital tubercle and
lower abdominal wall. The genital tubercle is formed by two
mesodermal bands (infraumbilical mesoderm) which grow
around from the dorsal aspect of the embryo and contribute to
the formation of the lower abdominal wall (Martinez-Frias et
al., 2001; Stadler, 2003), a similar process to the migration of
the abdominal bands. Failure of the infraumbilical mesoder-
mal bands to fuse or develop properly results in a split genital
tubercle and muscular defects in the lower abdominal wall
(Erb et al., 1992).
The mesodermal compartment of the body wall also
consists of a subset of the skeletal musculature, specifically
the thoracoabdominal muscles that extend into the body wall.
Skeletal muscles are formed from myogenic cells originating
from the somites (specifically the myotomes) and are com-
posed of mesoderm with some neural crest contribution
(Christ et al., 1983; Kenny-Mobbs, 1985; Ordahl and Le
Douarin, 1992). By utilizing skeletal muscle markers, it was
demonstrated that AP-2a is not necessary for muscle devel-
opment as a whole since skeletal muscle precursors are
observed migrating from the somites into the body wall
and muscles such as the intercostals and diaphragm are
formed in the knock-out mouse. However, AP-2a is required
for the formation of the lateral and ventral body wall muscles,
as these specific muscles are completely absent in the knock-
out. The absence of these latter muscles could reflect the
increase in apoptosis we observe in the body wall, or defects
in differentiation and/or migration. In this latter respect, AP-
2a knock-out mice would be similar to Pax3 mutant Splotch
mice. Splotch mice display a failure in the long-range
migration of muscle precursors, which would normally
contribute to the ventral components of the thoracic and
abdominal body wall musculature (Tremblay et al., 1998).
AP-2a null mice also lack the membrane that surrounds
the umbilical hernia, another malformation of the meso-
derm. This mesodermal membrane, which encloses the
midgut as it normally develops outside of the body, may
play a role both in returning the gut to the embryo proper
after development and closure of the ventral body wall at the
umbilical ring, as well as in protecting the internal organs
from contact with the amniotic fluid. The mesodermal
membrane surrounding the herniated gut is also absent in
Bmp-1 knock-out mice (Suzuki et al., 1996). Since BMP-1
is a procollagenase, Suzuki et al. (1996) examined the
extracellular matrix and found abnormalities in the collagen
fibrils. Based on this finding, they hypothesized that me-
chanical failure, alterations in cell adhesion, or inappropriate
proliferation and/or survival of cells in the ventral body
wall, amnion, or membrane surrounding the herniated gut
could result in the observed body wall defects. However,
these possibilities were not explored further (Suzuki et al.,
1996). The body wall is continuous with the membrane that
surrounds the gut, and with the amnion; therefore, it is
S. Brewer, T. Williams / Developmental Biology 267 (2004) 399–417414plausible that the changes in cell death in the body wall that
we have observed could adversely affect the development of
the membrane that surrounds the physiological hernia.
Alternatively, previous studies have also implicated the
AP-2a protein in the transcriptional regulation of matrix
metalloproteinases and cell adhesion molecules (Fini et al.,
1994; Hennig et al., 1996; West-Mays et al., 2003). There-
fore, it is also possible that loss of AP-2a could result in
body wall defects via changes in cell adhesion. At this
juncture, we should stress that, compared with the AP-2a
null mouse phenotype, the majority of mouse mutations
associated with ventral body wall pathology result in local-
ized and relatively minor closure defects (Eggenschwiler et
al., 1997; Hasty et al., 1993; Nabeshima et al., 1993;
Roebroek et al., 1998; Suzuki et al., 1996). More wide-
spread defects in body wall architecture occur in Tgfb2/
Tgfb3 double mutants as well as Hoxb2 or Hoxb4 knock-out
mice, affecting the primary body wall, the umbilicus, and
mesodermal derivatives (Dunker and Krieglstein, 2002;
Manley et al., 2001)—but these abnormalities are still not
as severe as the thoracoabdominoschisis seen in AP-2a null
embryos. Thus, it is probable that the AP-2a transcription
factor resides near the top of a genetic hierarchy regulating
ventral body wall closure. In the future, it will be interesting
to ascertain if AP-2a is involved in controlling expression
of one or more of the genes shown to be required for normal
mammalian body wall closure.
A possible role for AP-2a in epithelial–mesenchymal
interactions
Our study further suggests that AP-2a might be required
in the surface ectoderm for appropriate development of the
underlying mesoderm of the body wall. AP-2a is not
expressed in the mesodermal structures of the ventral body
wall, but is instead expressed in the surface ectoderm
beginning at E8.75 and persists here throughout develop-
ment (Byrne et al., 1994; Mitchell et al., 1991). Thus, the
absence of AP-2a specifically in the ectoderm of the
dorsolateral body wall of knock-out embryos could be
adversely affecting the formation of the mesodermal struc-
tures of the ventral body wall. In particular, there is an
apparent association between the extent of AP-2a expres-
sion in the differentiating dorsolateral epidermis and the
migration of the abdominal bands towards the ventral
surface. Our data show that the expression of AP-2a:LacZ
in the surface ectoderm of a wild-type embryo corresponds
to the limit of abdominal band migration. In contrast, in the
KI/KI embryo, AP-2a:LacZ expression in the surface ecto-
derm is halted at an abnormal dorsolateral position and this
correlates with the absence of the abdominal bands. This
suggests that the specific expression of AP-2a in the surface
ectoderm could affect the development and differentiation of
the mesodermal abdominal bands.
During an examination of AP-2a function in various
tissues using Cre-loxP methodology, we found that floxedAP-2a mice (Brewer et al., in press) crossed with Foxg1-
Cre transgenic mice (He´bert and McConnell, 2000) also
generated mutant embryos that had varying degrees of
ventral body wall closure defects. The observed abnormal-
ities in the fusion of the body wall folds were similar to
those seen in the studies of AP-2a chimeric mice (Nottoli et
al., 1998). Foxg1-Cre mice normally express Cre recombi-
nase in the telencephalon, but have also been shown to drive
Cre expression in patches of trunk ectoderm before E11.5
(He´bert and McConnell, 2000). Therefore, these data are
also consistent with our hypothesis that AP-2a functions as
a transcription factor in the ectoderm to regulate cell–cell
signaling pathways controlling development of the under-
lying mesoderm—and ultimately ventral body wall closure.
Note that other existing Cre lines (e.g., K14-Cre (Vasiou-
khin et al., 1999)) that are more specific to the ectoderm are
expressed too late in embryogenesis to be pertinent for the
process of ventral body wall formation and closure.
A further indication that the ectoderm might be a
critical sight of AP-2a function can be inferred from a
study of chimeric mice composed of wild-type and AP-2a
null cells (Nottoli et al., 1998). Interestingly, AP-2a null
cells were found to be severely underrepresented in the
skin of viable chimeric mice compared to the more
common distribution of these cells in other organs and
tissues (Nottoli, personal communication). We therefore
postulate that animals with a high percentage of AP-2a
null cells in the surface ectoderm will have severe epithe-
lial–mesenchymal signaling defects in the body wall,
which will ultimately lead to their death at birth or soon
after due to abnormalities such as thoracoabdominoschisis.
Thus, only animals with a predominately wild-type surface
ectoderm will survive. An important role for AP-2a in the
ectoderm and its derivatives is also supported by the
observation that later in mouse development the AP-2a
gene is involved in skin differentiation (Byrne et al., 1994;
Leask et al., 1991; Maytin et al., 1999). Moreover, studies
in the cephalochordate Amphioxus, a primitive chordate,
have implied that the ancestral role of AP-2 in vertebrate
evolution may reside within the developing ectoderm (Meu-
lemans and Bronner-Fraser, 2002).
The potential importance of AP-2a in the process of
epithelial–mesenchymal interactions is further supported by
the finding that the clavicles do not form in the absence of
AP-2a (Zhang et al., 1996). The clavicles are dermal bones
that normally form by intramembranous ossification follow-
ing an interaction between preclavicular mesodermal con-
densations and the overlying epidermis (Hall, 1986, 2001).
The lack of the clavicles in AP-2a knock-out mice provides
additional evidence that AP-2a expression in the ectoderm
may be important for correct development of these meso-
dermal derivatives. Finally, we note that there are additional
precedents for potential signals from the surface ectoderm
controlling the expression of genes in the dermomyotome of
the trunk (Fan and Tessier-Lavigne, 1994; Kuratani et al.,
1994).
S. Brewer, T. Williams / Developmental Biology 267 (2004) 399–417 415In summary, in this manuscript, we have developed a
framework for understanding the mechanisms underlying
body wall closure based on information that has been
gleaned from available mouse mutants and human body
wall theories. Overall, this analysis points to a central role
for epithelial–mesenchymal interactions in ventral body
wall closure, either in the transition at the umbilicus or in
cell–cell communication from the ectoderm to the meso-
derm of the body wall. In the future, as more mouse models
with ventral body wall closure defects become available, the
genetic hierarchy and tissue interactions required for this
critical developmental process will provide much needed
insight into the causes of related human birth defects.Acknowledgments
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